EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial

Alex Zvulunov iD, Stepan Lenevich iD, Natalia Migacheva iD

JMIR Dermatology · 22.01.2025 · 8 · e60479-e60479

DOI: 10.2196/60479 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Dermatology, online erschienen am 22.01.2025. Verfasst von Alex Zvulunov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sheba Medical Center and the Recanati School of Medicine, Reichman University, Tel Hashomer, Ramat-Gan, Israel, 972 584440189. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Mobile Applications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mobile health apps can boost treatment adherence and support disease management at home. The Atopic App and web-based Atopic School patient education program offer a chance to enhance adherence to atopic dermatitis (AD) management.

Objective

We aim to evaluate the feasibility, acceptability, and preliminary efficacy of the Atopic App mobile health intervention in the managing of AD in children.

Methods

A randomized controlled study in children with AD divided participants into 3 groups: a control group (no app), an observational group with the app, and an interventional group with investigator supervision. Patients were examined at screening and follow-up visits 1 and 2 at 3-month intervals. Outcome measures included SCORAD (Scoring Atopic Dermatitis) for objective severity and Patient-Oriented Eczema Measure (POEM) for subjective effectiveness. Statistical analysis used paired t tests (2-tailed), the Mann-Whitney U test, and multiple regression.

Results

Fifty-eight participants entered this study (38 boys and 20 girls): group 1 (control) comprised 17 patients, while experimental groups 2 and 3 consisted of 20 and 21 patients, respectively. The rates of missed appointments were similar and statistically insignificant across the groups. All groups showed a significant decrease in SCORAD and POEM scores ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicMobile ApplicationsHumansMaleFemaleChildAdolescentSeverity of Illness IndexTelemedicinePatient Education as TopicChild, PreschoolFeasibility Studies

Stichwörter der Autor:innen

Atopic Appappatopic dermatitischildrendermatologydisease managementeczemafeasibilitymHealthmobile healthpediatricskin

Autor:innen und Institutionen

  • Sheba Medical Center and the Recanati School of Medicine, Reichman University, Tel Hashomer, Ramat-Gan, Israel, 972 584440189.
  • AvantaTrading Ltd, Moscow, Russian Federation.
  • Department of Pediatrics, Samara State Medical University, Samara, Russian Federation.

ORCID-Profile: Alex Zvulunov, Stepan Lenevich, Natalia Migacheva

Zitieren

APA

Zvulunov, A., Lenevich, S., & Migacheva, N. (2025). Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial. JMIR Dermatology, 8, e60479-e60479. https://doi.org/10.2196/60479

Vancouver

Zvulunov A, Lenevich S, Migacheva N. Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial. JMIR Dermatology. 2025;8:e60479-e60479. doi:10.2196/60479

BibTeX
@article{Zvulunov2025,
  author = {Zvulunov, Alex and Lenevich, Stepan and Migacheva, Natalia},
  title = {Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial},
  journal = {JMIR Dermatology},
  year = {2025},
  volume = {8},
  pages = {e60479--e60479},
  doi = {10.2196/60479}
}
Kostenlos starten →